Impact of intra-host population structure on influenza virus antigenic evolution

宿主内群体结构对流感病毒抗原进化的影响

基本信息

  • 批准号:
    10349407
  • 负责人:
  • 金额:
    $ 38.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-12-09 至 2026-11-30
  • 项目状态:
    未结题

项目摘要

SUMMARY At the global population level, seasonal influenza A virus (IAV) evolution is characterized by repeated selective sweeps in which novel antigenic variants that escape antibody responses replace previously circulating strains. Despite this clear pattern at a population level, selection of antigenic variants is not typically seen within individuals with acute IAV infection. This apparent disconnect between evolutionary processes at population and within-host scales contributes to the challenge of predicting evolutionary outcomes. The processes that impede IAV selection within the host, and their potency, have not been examined systematically. To address this knowledge gap, we will test the central hypothesis that the genetic structure of within-host viral populations plays a major role in defining the likelihood that a beneficial mutation becomes fixed. In particular, we hypothesize that the fate of a highly fit variant virus is shaped by its initial prevalence in the inoculum (quantitative structure), the timing with which it arises de novo (temporal structure), its location within the infected tissue (spatial structure) and the presence or absence of competing variants (clonal interference). In turn, we predict that onward transmission of a beneficial variant will rely on a combination of these factors and the stringency of the transmission bottleneck. We furthermore propose that the severity of the bottleneck is modulated by pre-existing immunity in the host. To test these hypotheses, we will monitor the dynamics of mixed viral populations containing a seasonal IAV and one or two HA antigenic variants thereof within individual guinea pigs and between transmission partners. Partial immunity will be induced with vaccination to yield a model in which the antigenic variants have a selective advantage. Distinct sequence barcodes will be included in the HA and NA genes of each virus to allow sensitive detection of genetic bottlenecks. Tracking barcodes in both HA and NA will allow genetic linkage to be assessed. The wild type and antigenic variant viruses will be combined in vivo with various quantitative, temporal and spatial structures and then barcode dynamics will be monitored by sequencing. With this approach, we will perform a systematic evaluation of the consequences of population genetic structure for viral evolutionary dynamics. This well-controlled and systematic approach will allow identification of processes that impede selection within and between individual hosts, providing much needed insight into the forces shaping IAV evolution where it begins.
总结 在全球人群水平上,季节性甲型流感病毒(IAV)进化的特征是重复的选择性 新的抗原变异体逃避了抗体反应,取代了以前流行的病毒株。 尽管在群体水平上有这种明确的模式,但抗原变体的选择通常在群体中并不常见。 急性IAV感染者。这种明显的脱节,在人口的进化过程, 宿主内尺度有助于预测进化结果的挑战。阻碍的过程 IAV在宿主中的选择性及其效力尚未得到系统的研究。为了解决这个 知识差距,我们将测试中心假设,即宿主内病毒种群的遗传结构发挥作用, 在定义有益突变被修复的可能性方面发挥着重要作用。特别是,我们假设, 高度适合的变异病毒的命运是由其在接种物中的初始流行度(定量结构)决定的, 它重新出现的时间(时间结构),它在感染组织中的位置(空间结构) 以及竞争变体的存在或不存在(克隆干扰)。反过来,我们预测, 有益变体的传播将依赖于这些因素的组合和疫苗的严格性。 传输瓶颈我们还提出,瓶颈的严重程度是由预先存在的调制 宿主免疫力。为了验证这些假设,我们将监测混合病毒种群的动态 含有季节性IAV和其一种或两种HA抗原变体的豚鼠个体内和 传输伙伴。部分免疫将用疫苗接种诱导,以产生其中抗原性免疫的模型。 变体具有选择性优势。不同的序列条形码将被包括在重组人的HA和NA基因中。 每种病毒都能灵敏地检测出基因瓶颈。HA和NA中的跟踪条形码将允许 基因连锁有待评估。野生型和抗原性变体病毒将在体内与各种抗原性变体病毒组合。 定量、时间和空间结构,然后通过测序监测条形码动力学。与 通过这种方法,我们将对群体遗传结构的后果进行系统的评估, 病毒进化动力学这种控制良好的系统方法将允许识别过程 阻碍个体宿主内部和宿主之间的选择,提供了急需的洞察力, IAV进化的起点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anice C Lowen其他文献

Anice C Lowen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anice C Lowen', 18)}}的其他基金

Role of Type I and III Interferons in Shaping Influenza A Virus Dynamics Within and Between Hosts
I 型和 III 型干扰素在塑造甲型流感病毒宿主内部和之间动态中的作用
  • 批准号:
    10681893
  • 财政年份:
    2023
  • 资助金额:
    $ 38.67万
  • 项目类别:
Impact of intra-host population structure on influenza virus antigenic evolution
宿主内群体结构对流感病毒抗原进化的影响
  • 批准号:
    10538597
  • 财政年份:
    2021
  • 资助金额:
    $ 38.67万
  • 项目类别:
Development of Oncolytic Reovirus for Triple-Negative Breast Cancer
用于三阴性乳腺癌的溶瘤呼肠孤病毒的开发
  • 批准号:
    10084268
  • 财政年份:
    2020
  • 资助金额:
    $ 38.67万
  • 项目类别:
Development of Oncolytic Reovirus for Triple-Negative Breast Cancer
用于三阴性乳腺癌的溶瘤呼肠孤病毒的开发
  • 批准号:
    10319586
  • 财政年份:
    2020
  • 资助金额:
    $ 38.67万
  • 项目类别:
Host dependence of influenza A virus reassortment
甲型流感病毒重组的宿主依赖性
  • 批准号:
    9219126
  • 财政年份:
    2016
  • 资助金额:
    $ 38.67万
  • 项目类别:
Host dependence of influenza A virus reassortment
甲型流感病毒重组的宿主依赖性
  • 批准号:
    10058805
  • 财政年份:
    2016
  • 资助金额:
    $ 38.67万
  • 项目类别:
Reassortment of influenza viruses in a co-infected host
共感染宿主中流感病毒的重排
  • 批准号:
    8549943
  • 财政年份:
    2012
  • 资助金额:
    $ 38.67万
  • 项目类别:
Reassortment of influenza viruses in a co-infected host
共感染宿主中流感病毒的重排
  • 批准号:
    8899423
  • 财政年份:
    2012
  • 资助金额:
    $ 38.67万
  • 项目类别:
Reassortment of influenza viruses in a co-infected host
共感染宿主中流感病毒的重排
  • 批准号:
    8439377
  • 财政年份:
    2012
  • 资助金额:
    $ 38.67万
  • 项目类别:
Reassortment of influenza viruses in a co-infected host
共感染宿主中流感病毒的重排
  • 批准号:
    8711262
  • 财政年份:
    2012
  • 资助金额:
    $ 38.67万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.67万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.67万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.67万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.67万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.67万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.67万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.67万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.67万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.67万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.67万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了